


The Fund aims to achieve above average capital growth.
| Name | % Net Assets | 
|---|---|
| DIRECTV Group Inc. | 8.0% | 
| Oracle Corp. | 3.8% | 
| JPMorgan Chase & Co. | 3.6% | 
| Wells Fargo & Co. | 3.4% | 
| UnitedHealth Group Inc. | 3.0% | 
| DaVita Inc. | 3.0% | 
| Pfizer Inc. | 3.0% | 
| Airgas Inc. | 2.9% | 
| Crown Castle International Corp. | 2.5% | 
| Amgen Inc. | 2.5% | 
| Key | % Net Assets | 
|---|---|
| 8.0% | |
| 3.8% | |
| 3.6% | |
| 3.4% | |
| 81.2% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 628.53p | 
| Currency | GBP | 
| Change | -2.24p | 
| % | -0.36% | 
| YTD change | -31.68p | 
| YTD % | -4.80% | 
| Fund Inception | 31/03/1982 | 
|---|---|
| Fund Manager | Cormac Weldon | 
| TER | 1.67 (30-Mar-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £2000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | -0.04 | 
You are here: research